Methemoglobin to cumulative nitric oxide ratio and response to inhaled nitric oxide in PPHN

J Perinatol. 2009 Oct;29(10):698-701. doi: 10.1038/jp.2009.69. Epub 2009 Jun 25.

Abstract

Background: One-third of infants with persistent pulmonary hypertension of the newborn (PPHN) do not respond to inhaled nitric oxide (iNO). If iNO is not delivered to the pulmonary vasculature because of parenchymal lung disease, it cannot interact with hemoglobin to form methemoglobin (MHb).

Objective: To study the correlation between oxygenation response to iNO in infants with PPHN secondary to parenchymal lung disease and initial MHb% to cumulative NO exposure (ppm x hours) ratio (MHb/SigmaNO).

Study design: Retrospective chart review of neonates with PPHN secondary to parenchymal lung disease treated with iNO comparing non-responders (PaO(2)/FiO(2) ratio<10 change with iNO) with responders (>or=10 change).

Result: Non-responders (n=16) had a PaO(2)/F(iO2) of 83+/-48 (mean+/-s.d.) and decreased to 74+/-44 after iNO. PaO(2)/FiO(2) increased from 70+/-48 to 151+/-63 with iNO among responders (n=36). The MHb/SigmaNO ratio was low (0.024+/-0.012) among non-responders compared with responders (0.07+/-0.053, P<0.005).

Conclusion: Inadequate oxygenation response to iNO is associated with lower MHb/SigmaNO, suggesting suboptimal delivery of iNO to the pulmonary vasculature.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Inhalation
  • Blood Gas Analysis
  • Case-Control Studies
  • Dose-Response Relationship, Drug
  • Drug Monitoring
  • Humans
  • Infant, Newborn
  • Meconium Aspiration Syndrome / complications
  • Methemoglobin / analysis*
  • Methemoglobin / metabolism
  • Nitric Oxide / administration & dosage*
  • Nitric Oxide / blood*
  • Persistent Fetal Circulation Syndrome / complications
  • Persistent Fetal Circulation Syndrome / drug therapy*
  • Pneumonia, Aspiration / complications
  • Respiratory Distress Syndrome, Newborn / complications
  • Retrospective Studies
  • Treatment Failure
  • Vasodilator Agents / administration & dosage*
  • Vasodilator Agents / blood*

Substances

  • Vasodilator Agents
  • Nitric Oxide
  • Methemoglobin